elranatamab will raise the degree or influence of ergotamine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Elranatamab triggers cytokine launch syndrome (CRS) which could suppress activity of CYP enzymes, leading to amplified exposure of CYP substrates.When you have any issues or call for even further aid con… Read More